These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6173691)

  • 1. Demonstration of potentiation of the antiviral and antitumor actions of interferon.
    Fleischmann WR; Schwarz LA
    Methods Enzymol; 1981; 79(Pt B):432-40. PubMed ID: 6173691
    [No Abstract]   [Full Text] [Related]  

  • 2. Potentiation of antitumor effect of virus-induced interferon by mouse immune interferon preparations.
    Fleischmann WR; Kleyn KM; Baron S
    J Natl Cancer Inst; 1980 Nov; 65(5):963-6. PubMed ID: 6159498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of interferon treatment on the tumour-specific antibody response of BALB-c mice infected with Rauscher virus.
    Tóth FD; Váczi L; Berencsi C
    Acta Microbiol Acad Sci Hung; 1971; 18(2):109-12. PubMed ID: 4337368
    [No Abstract]   [Full Text] [Related]  

  • 4. Interferon-inducibility is diminished in tumour-bearing mice.
    Hung PL; Stöger I; Karczag E; Minárovics J; Földes I
    Acta Microbiol Hung; 1989; 36(4):433-8. PubMed ID: 2484273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of interferon on multiplication of Friend leukemia cells in vivo.
    Rossi GB; Marchegiani M; Matarese GP; Gresser I
    J Natl Cancer Inst; 1975 Apr; 54(4):993-6. PubMed ID: 1127730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo response of mitoxantrone and doxorubicin with dipyrone in parental and doxorubicin-resistant P388 leukemia.
    Kamath NS; Chitnis MP
    Oncology; 1990; 47(2):166-9. PubMed ID: 2314829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological evaluation of combination therapy of P388 leukemia with cyclophosphamide and pyrimidinones.
    Li LH; Wallace TL; Hamilton RD; DeKoning TF
    Int J Immunopharmacol; 1987; 9(1):31-9. PubMed ID: 3583503
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of finoptin on doxorubicin accumulation in leukemia P-388 cells with induced resistance to the combination of finoptin and doxorubicin].
    Moroz LV; Donenko FV; Borovkova NB; Sitdikova SM; Kabieva AO
    Biull Eksp Biol Med; 1990 Mar; 109(3):290-2. PubMed ID: 2364157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraperitoneal chemotherapy with melphalan plus glutaminase.
    Holcenberg J; Anderson T; Ritch P; Skibba J; Howser D; Ring B; Adams S; Helmsworth M
    Cancer Res; 1983 Mar; 43(3):1381-8. PubMed ID: 6825107
    [No Abstract]   [Full Text] [Related]  

  • 10. Tolerance of mouse tissues to stimulation of interferon.
    Blach-Olszewska Z; Skurska Z
    Arch Immunol Ther Exp (Warsz); 1974; 22(4):435-44. PubMed ID: 4479568
    [No Abstract]   [Full Text] [Related]  

  • 11. Potentiation of interferon action.
    Schwarz LA; Fleischmann WR
    Tex Rep Biol Med; 1981-1982; 41():298-306. PubMed ID: 6184817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
    Borden EC; Sidky YA; Hatcher JF; Bryan GT
    Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 3'-amino-3'-deoxythymidine on L1210 and P388 leukemias in mice.
    Lin TS; Fischer PH; Prusoff WH
    Biochem Pharmacol; 1982 Jan; 31(1):125-8. PubMed ID: 7059345
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy of P388 leukemia with benzaldehyde.
    Balázová E; Koza I
    Neoplasma; 1988; 35(6):725-8. PubMed ID: 3221939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of mouse hepatitis virus infection on combination therapy of P388 leukemia with cyclophosphamide and pyrimidinones.
    Li LH; DeKoning TF; Nicholas JA; Kramer GD; Wilson D; Wallace TL; Collins MJ
    Lab Anim Sci; 1987 Feb; 37(1):41-4. PubMed ID: 3035278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the therapeutic effects of free and liposomally encapsulated vincristine in leukemic mice.
    Layton D; Trouet A
    Eur J Cancer (1965); 1980 Jul; 16(7):945-50. PubMed ID: 7428786
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction and production of L cell interferon.
    Kawade Y; Yamamoto Y
    Methods Enzymol; 1981; 78(Pt A):139-43. PubMed ID: 6173578
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.
    Li LH; Wallace TL; Richard KA; Tracey DE
    Cancer Res; 1985 Feb; 45(2):532-8. PubMed ID: 3967227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon and friend virus-induced leukemic cells: in vivo and in vitro interactions.
    Rossi GB; Matarese GP; Marchegiani M; Grappelli C
    Boll Ist Sieroter Milan; 1974; 53(4):538-42. PubMed ID: 4451582
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined therapy with an aziridine derivative NSC 200724 (AB182) and radiation on an experimental leukemia.
    Wodinsky I; Clement J; Swiniarski J; Skura A
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1677-80. PubMed ID: 536276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.